Jr. Hess et al., INCREASED VASCULAR-RESISTANCE WITH HEMOGLOBIN-BASED OXYGEN CARRIERS, Artificial cells, blood substitutes, and immobilization biotechnology, 22(3), 1994, pp. 361-372
Purpose: To compare the effects of resuscitation with hemoglobin-based
oxygen-carriers and conventional resuscitation fluids on hemodynamics
, oxygen transport, and oxygen consumption in an animal model of the u
se of these fluids in the treatment of hemorrhagic shock. Protocol: Tw
enty-eight immature swine were surgically prepared, allowed to recover
five days, water deprived for 48 hours, hemorrhaged of 25 ml/kg over
one hour, resuscitated promptly with 1) Ringer's lactate, 75 ml/kg, 2)
7% albumin in Ringer's acetate, 25 ml/kg, 3) 9% unmodified hemoglobin
in Ringer's acetate, 25 ml/kg, or 4) 9% cra-crosslinked hemoglobin in
Ringer's acetate, 25 ml/kg, and observed with three hours of hemodyna
mic and oxygen transport measurements. Results: Systemic and pulmonary
vascular resistance were increased in hemoglobin-treated animals to m
ore than twice the levels seen in crystalloid- or colloid-treated cont
rols. Oxygen consumption and the rate of correction of lactic acidosis
were not increased in hemoglobin-treated animals. Conclusions: Increa
sed vascular resistance limits the oxygen transport benefit of cell-fr
ee-hemoglobin-based oxygen carriers. Cell-free-hemoglobin-induced incr
eases in vascular resistance may place animals' hearts on an unfavorab
le portion of the Frank-Starling curve as well as complicate further m
edical treatment by reducing the animals' tolerance to increases in bl
ood viscosity.